Reverse translational research based on a novel pharmacokinetic control theory for immunosuppressive drugs
Project/Area Number |
20K16080
|
Research Category |
Grant-in-Aid for Early-Career Scientists
|
Allocation Type | Multi-year Fund |
Review Section |
Basic Section 47060:Clinical pharmacy-related
|
Research Institution | University of Miyazaki |
Principal Investigator |
|
Project Period (FY) |
2020-04-01 – 2023-03-31
|
Project Status |
Completed (Fiscal Year 2022)
|
Budget Amount *help |
¥4,290,000 (Direct Cost: ¥3,300,000、Indirect Cost: ¥990,000)
Fiscal Year 2022: ¥1,040,000 (Direct Cost: ¥800,000、Indirect Cost: ¥240,000)
Fiscal Year 2021: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2020: ¥1,950,000 (Direct Cost: ¥1,500,000、Indirect Cost: ¥450,000)
|
Keywords | 免疫抑制薬 / タクロリムス / 赤血球 / FKBP / 薬物動態 |
Outline of Research at the Start |
タクロリムスは薬物体内動態の個人差が極めて大きい薬物である。本研究では、これまで不明であった生体内でのタクロリムスの赤血球移行におけるFKBPの役割を明らかにし、新たなタクロリムスの体内動態制御理論を構築することを目的とする。タクロリムスの赤血球移行機序に着眼し、赤血球移行においてFKBPが果たす役割とその寄与率を明らかにすることで、FKBPによるタクロリムスの体内動態制御機構を初めて証明する。本研究は、臨床で生じた課題に対しリバーストランスレーショナルなアプローチを行う。
|
Outline of Final Research Achievements |
In this study, we attempted to clarify the role of FK506 binding protein (FKBP) in the red blood cells (RBCs) distribution of tacrolimus in vivo by elucidating the intracellular distribution mechanism of tacrolimus based on its interaction with FKBP. It was suggested that the capture of tacrolimus by FKBP12 prior to its contact with RBCs decreases the RBCs distribution of tacrolimus. In addition, the contribution of intracellular FKBP12 molecules was found to be extremely significant in the intracellular distribution of tacrolimus.
|
Academic Significance and Societal Importance of the Research Achievements |
本研究において、生体内でのタクロリムスの赤血球移行におけるFKBPの役割を一部明らかにした。本成果は、これまで不明であったタクロリムスの赤血球移行機序において、FKBPが果たす役割とその寄与率の解明に迫るものと考える。本研究成果はタクロリムスの新たな体内動態制御理論の構築につながる極めて有益な知見である。
|
Report
(4 results)
Research Products
(43 results)
-
-
-
-
-
[Journal Article] Fine-tuned cholesterol solubilizer, mono-6-O-α-D-maltosyl-γ-cyclodextrin, ameliorates experimental Niemann?Pick disease type C without hearing loss2022
Author(s)
Yamada Y, Miwa T, Nakashima M, Shirakawa A, Ishii A, Namba N, Kondo Y, Takeo T, Nakagata N, Motoyama K, Higashi T, Arima H, Kurauchi Y, Seki T, Katsuki H, Okada Y, Ichikawa A, Higaki K, Hayashi K, Minami K, Yoshikawa N, Ikeda R, Ishikawa Y, Kajii T, Tachii K, Takeda H, Orita Y, Matsuo M, Irie T, Ishitsuka Y
-
Journal Title
Biomedicine & Pharmacotherapy
Volume: 155
Pages: 113698-113698
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
[Journal Article] Ursodeoxycholic acid markedly promotes the absorption of microemulsion-formulated cyclosporine A: A case report2022
Author(s)
Takeshima, H., Yoshikawa, N., Akizuki, K., Hidaka, T., Shimoda, K., Ikeda, R.
-
Journal Title
Journal of Clinical Pharmacy and Therapeutics
Volume: 47
Issue: 2
Pages: 260-262
DOI
Related Report
Peer Reviewed
-
[Journal Article] The Cytokine Expression in Patients with Cardiac Complication after Immune Checkpoint Inhibitor Therapy2021
Author(s)
Tsuruda T, Yoshikawa N, Kai M, Yamaguchi M, Toida R, Kodama T, Kajihara K, Kawabata T, Nakamura T, Sakata K, Hatakeyama K, Gi T, Asada Y, Tono T, Kitamura K, Ikeda R.
-
Journal Title
Internal Medicine
Volume: 60
Issue: 3
Pages: 423-429
DOI
NAID
ISSN
0918-2918, 1349-7235
Year and Date
2021-02-01
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Relationship between CYP3A5 Polymorphism and Tacrolimus Blood Concentration Changes in Allogeneic Hematopoietic Stem Cell Transplant Recipients during Continuous Infusion2021
Author(s)
Yoshikawa, N., Takeshima, H., Sekine, M., Akizuki, K., Hidaka, T., Shimoda, K., Ikeda, R.
-
Journal Title
Pharmaceuticals
Volume: 14
Issue: 4
Pages: 353-353
DOI
Related Report
Peer Reviewed / Open Access
-
[Journal Article] Delayed methotrexate elimination in a patient with primary central nervous system lymphoma: A case report2021
Author(s)
Urata, S., Yoshikawa, N, Saito, K., Tazaki, T., Ohno, R., Takeshima, H., Ikeda, R.
-
Journal Title
Journal of Clinical Pharmacy and Therapeutics
Volume: 46
Issue: 6
Pages: 1796-1799
DOI
Related Report
Peer Reviewed
-
-
-
-
[Journal Article] Development and Validation of an HPLC Method for Analysis of Topotecan in Human Cerebrospinal Fluid and Its Application in Elimination Evaluation of Topotecan after Intraventricular Injection2021
Author(s)
Yoshikawa,N., Yamada, A., Yokota, T., Yamada,Y., Kinoshita, M., Moritake, H., Ikeda, R.
-
Journal Title
Cancers
Volume: 13
Issue: 18
Pages: 4643-4643
DOI
Related Report
Peer Reviewed / Open Access
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-